Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow (FCF).

1093 Free Cash Flow Analysis

Free cash flow, a measure commonly used by analysts to assess a company's profitability, represents the cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

The Free Cash Flow is calculated using a number of methods including using Operating Cash Flow. Following is the formula to calculate Free Cash Flow based on Operating Cash Flow.

Free Cash Flow = Operating Cash Flow - Capital Expenditures

Using above formula to calculate Free Cash Flow for CSPC Pharmaceutical Group Limited (1093), the free cash flow value is 3.226481B.

All amounts in CNY

Operating Cash
Capital Expenditure
Free Cash Flow

CSPC Pharmaceutical Group Limited has a positive free cash flow as per the latest annual Cash flow statement released by the company. Positive free cash flow is cruscial for the financial health of a company, which can be used to pay dividends, expand operations, and deleverage its balance sheet (i.e., reduce debt).

1093 Cash Flow Statement History

Following table shows the history of Cash Flow Statements sheet for CSPC Pharmaceutical Group Limited (HKEX:1093).

31 Dec 2021 31 Dec 2020 31 Dec 2019 31 Dec 2018
Net Income 5.61B 5.16B 3.71B 3.08B
Depreciation 862.38M 804.45M 686.67M 607.41M
Change To Netincome -446.11M -909.03M -136.99M -145.9M
Change To Account Receivables -943.55M -445.45M -196.74M -519.66M
Change To Liabilities 232.57M 629.28M -572.97M 593.83M
Change To Inventory -617.07M 601.44M 509.31M -614.03M
Change To Operating Activities -59.87M 894.92M -224.41M 770.4M
Total Cash From Operating Activities 4.64B 6.74B 3.78B 3.8B
Capital Expenditures -1.41B -1.36B -1.88B -1.67B
Investments 630.71M -450.06M 261.06M -1.44B
Other Cashflows From Investing Activities 269M -10.01M -267.2M -190.05M
Total Cashflows From Investing Activities -637.33M -2.13B -2.46B -3.63B
Dividends Paid -1.69B -1.53B -965.38M -782.88M
Net Borrowings -222.17M 76.68M -1.63B 714.11M
Other Cashflows From Financing Activities -20.16M -19.96M 1.15B 809k
Total Cash From Financing Activities -2.2B -1.47B -1.55B -151.39M
Effect Of Exchange Rate -2.44M 2.1M 1.46M 3.01M
Change In Cash 1.8B 3.14B -217.38M 19.05M
Repurchase Of Stock -263.51M -263.51M -100.71M -83.43M